A Message from President DePinho

 

Dear Colleague,

Partnering with you and your patients remains a priority for the faculty and staff of The University of Texas MD Anderson Cancer Center, and we are grateful for your trust as we strive to best serve you, your patients and their families.

Our Guide for Referring Physicians is an online resource that delivers the most up-to-date information on our more than 800 clinical oncologists and medical specialists. Its print-on-demand feature allows you to download and print the full guide or to completely customize it for your use. The result is information for you that is timely, accurate and tailored.

This guide also provides a number of other features, including:

Referring physicians have provided us with numerous ideas about ways we can improve how we deliver services and information to you and your patients. And we have taken them to heart.

  • We’ve improved access and communications via myMDAnderson for Physicians. This secure portal allows you 24-hour access to refer patients, view dictated patient reports and appointment schedules, read about clinical trials and update your contact information. • We also have integrated our electronic medical record into the myMDAnderson portal. This provides access to your patients’ clinical laboratory, pathology and radiology reports.
  • We’ve simplified the medical acceptance process to make it easier — and faster — for you and your staff to obtain appointments for your patients. Many of our clinics offer same-day or next-day appointment scheduling.
  • We’ve also completed implementation of a physician call center to provide clinical support and information to you and your office staff. Call 1-800-252-0502 to speak with a Physician Relations Specialist for immediate help. Or contact one of our physicians directly, if you have specific questions about a patient.

This is an exciting time to lead MD Anderson Cancer Center, as we have launched our innovative Cancer Moon Shots Program — the boldest, and most promising, initiative ever undertaken here or at any single institution devoted to eliminating cancer. Supported by MD Anderson’s robust research and clinical infrastructure, unique drug discovery capabilities and global academic network, the program will have short-term and long-range impact across the spectrum of cancer prevention and early detection, treatment and survival. The program’s primary objective — achieving measurable success in the reduction of cancer deaths — will require focused effort on the part of all of us here, with the assistance and input of many others, including referring physicians from countless communities.

Please remember, we always are looking for ways to improve our services and relationships, so don’t hesitate to share your thoughts with us. We look forward to our continued partnership.

Thank you,

Dr. Ronald DePinho
President, The University of Texas MD Anderson Cancer Center